Nils Nicolay, Professor and Chair of the Department of Radiation Oncology at the University of Leipzig Medical Center, shared a post on LinkedIn about a paper he co-authored with colleagues published in Radiotherapy and Oncology:
“What is the ideal ‘precision’ for precisely treating bone oligometastases?
The stereotactic RT team of the Department of Radiation Oncology has just published a thought-provoking paper in Radiotherapy and Oncology:
- Higher treatment doses to bone metastases correlated with improved progression-free and biochemical recurrence-free survival in patients with oligometastatic prostate cancer.
- Patients treated for the whole metastatic “compartment” rather than only the visible lesion had better outcomes
More data to follow shortly…
A big cheers to the working group SRS/SBRT of the Deutsche Gesellschaft für Radioonkologie (DEGRO) e. V. and the many national and international partners participating in this European research project !”
Title: Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases − a European multicenter cohort study
Authors: Isabell Seiler, Sebastian Schäfer, Camilla von Wachter, Panagiotis Balermpas, Marek Slavik, Petr Burkon, Johannes Meents, Lena Kästner, Fabian Lohaus, Jochen Willner, Anna Sabrina Schunn, Sophia Drabke, Kenneth Klischies, Olaf Wittenstein, Priska Bank, Richard Partl, Jörg-Andreas Müller, Ahmed Gawish, Arne Grün, Andrea Baehr, Maike Trommer, Andrea Glasmacher, Thomas Mader, Richard Holy, Yvonne Dzierma, Felix Ehret, Alexander Rühle, Matthias Guckenberger, Christos Moustakis, Thomas Brunner, Oliver Blanck, Judit Boda-Heggemann, Nils H. Nicolay, Franziska Nägler
You can read the full article in Radiotherapy and Oncology.
More posts featuring Nils Nicolay.